HealthEquity, Inc. $HQY Holdings Raised by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. grew its position in HealthEquity, Inc. (NASDAQ:HQY) by 42.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 106,922 shares of the company’s stock after acquiring an additional 31,716 shares during the quarter. Oppenheimer Asset Management Inc. owned approximately 0.12% of HealthEquity worth $11,201,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Farther Finance Advisors LLC increased its holdings in shares of HealthEquity by 232.4% in the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after acquiring an additional 172 shares during the last quarter. WPG Advisers LLC acquired a new stake in HealthEquity in the first quarter worth $28,000. Caitong International Asset Management Co. Ltd acquired a new stake in HealthEquity in the second quarter worth $33,000. Cullen Frost Bankers Inc. increased its position in HealthEquity by 172.3% in the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after buying an additional 224 shares during the period. Finally, Northwestern Mutual Wealth Management Co. increased its position in HealthEquity by 176.4% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company’s stock worth $58,000 after buying an additional 418 shares during the period. 99.55% of the stock is currently owned by institutional investors.

Insider Activity

In related news, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the transaction, the executive vice president owned 49,795 shares of the company’s stock, valued at $4,392,416.95. This trade represents a 3.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Delano Ladd sold 6,000 shares of the firm’s stock in a transaction dated Friday, September 19th. The shares were sold at an average price of $94.11, for a total value of $564,660.00. Following the transaction, the executive vice president directly owned 79,456 shares of the company’s stock, valued at $7,477,604.16. This represents a 7.02% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 9,281 shares of company stock valued at $859,867 in the last ninety days. Company insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on HQY. Barrington Research reaffirmed an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a research report on Friday, August 29th. KeyCorp dropped their target price on HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Royal Bank Of Canada increased their target price on HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 3rd. Raymond James Financial reissued a “strong-buy” rating and issued a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Finally, Jefferies Financial Group increased their price target on HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research note on Wednesday, September 3rd. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $121.31.

HealthEquity Trading Up 0.2%

Shares of HQY stock opened at $96.50 on Monday. The stock has a 50-day simple moving average of $92.21 and a 200 day simple moving average of $94.67. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The stock has a market capitalization of $8.31 billion, a P/E ratio of 58.49, a P/E/G ratio of 1.39 and a beta of 0.47. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 2nd. The company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%.The business had revenue of $325.80 million during the quarter, compared to analysts’ expectations of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. On average, sell-side analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.